Cyanotech Corp financial data

Symbol
CYAN on OTC
Industry
Medicinal Chemicals & Botanical Products
Location
73 4460 Queen Kaahumanu Hwy, Suite 102, Kailua Kona, HI
State of incorporation
NV
Fiscal year end
March 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 118 % -33.8%
Quick Ratio 83 % -40.5%
Debt-to-equity 119 % +42.1%
Return On Equity -47.4 % -79.6%
Return On Assets -21.7 % -50.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.16M shares +10.3%
Common Stock, Shares, Outstanding 7.14M shares +10.3%
Entity Public Float 3.33M USD -59.1%
Common Stock, Value, Issued 143K USD +10.9%
Weighted Average Number of Shares Outstanding, Basic 7M shares +10%
Weighted Average Number of Shares Outstanding, Diluted 7M shares +10%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 23.3M USD +2.16%
Research and Development Expense 544K USD -20.5%
Selling and Marketing Expense 4.96M USD -2.75%
General and Administrative Expense 4.54M USD +1.27%
Operating Income (Loss) -4.77M USD -36.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.45M USD -30.4%
Income Tax Expense (Benefit) 5K USD -70.6%
Net Income (Loss) Attributable to Parent -5.45M USD -30%
Earnings Per Share, Basic -0.79 USD/shares -17.9%
Earnings Per Share, Diluted -0.79 USD/shares -17.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 780K USD -36.9%
Accounts Receivable, after Allowance for Credit Loss, Current 1.59M USD +11.3%
Inventory, Net 7.19M USD -25.1%
Assets, Current 10.1M USD -20.2%
Property, Plant and Equipment, Net 9.51M USD -11.8%
Operating Lease, Right-of-Use Asset 4.16M USD -8.23%
Other Assets, Noncurrent 122K USD +38.6%
Assets 23.9M USD -14.8%
Accounts Payable, Current 2.13M USD +53.2%
Accrued Liabilities, Current 619K USD -31%
Contract with Customer, Liability, Current 272K USD +114%
Liabilities, Current 9.58M USD +10.6%
Operating Lease, Liability, Noncurrent 3.65M USD -9.21%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 14.2M USD +3.99%
Retained Earnings (Accumulated Deficit) -25.3M USD -27.5%
Stockholders' Equity Attributable to Parent 9.69M USD -32.7%
Liabilities and Equity 23.9M USD -14.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 243K USD
Net Cash Provided by (Used in) Financing Activities -183K USD -144%
Net Cash Provided by (Used in) Investing Activities -47K USD +68.7%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 7.14M shares +10.3%
Common Stock, Par or Stated Value Per Share 0.02 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 13K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 974K USD -62.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 164K USD +8.61%
Deferred Tax Assets, Valuation Allowance 4.39M USD +47%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 6.51M USD +20.5%
Operating Lease, Liability 4.18M USD -7.59%
Lessee, Operating Lease, Liability, to be Paid 5.7M USD -9.05%
Property, Plant and Equipment, Gross 37.5M USD +0.62%
Operating Lease, Liability, Current 533K USD +5.34%
Lessee, Operating Lease, Liability, to be Paid, Year Two 831K USD +2.47%
Lessee, Operating Lease, Liability, to be Paid, Year One 822K USD +102%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.52M USD -12.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 524K USD -34.1%
Deferred Tax Assets, Operating Loss Carryforwards 4.47M USD +25.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 395K USD -50.8%
Additional Paid in Capital 34.8M USD +2.13%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.53M USD -6.31%
Deferred Tax Assets, Net of Valuation Allowance 2.11M USD -12.4%
Interest Expense 681K USD +0.44%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%